Get started
Author

Margarita Žvirblė

Observed names: M. Zvirble, MARGARITA ZVIRBLE, Margarita Zvirble
ORCID: 0000-0002-4598-0108
Observed ORCID: 0000-0002-4598-0108
OpenAlex ID: A5063105392
Prognostic significance of soluble PD-L1 in prostate cancer
2024 · Margarita Zvirble, Zilvinas Survila, et al. · Frontiers in Immunology · 12
PDF
Liquid-Based Diagnostic Panels for Prostate Cancer: The Synergistic Role of Soluble PD-L1, PD-1, and mRNA Biomarkers
2025 · Margarita Žvirblė, Ieva Vaicekauskaitė, et al. · International Journal of Molecular Sciences · 6
PDF
Doxorubicin uptake in ascitic lymphoma model: resistance or curability is governed by tumor cell density and prolonged drug retention
2020 · Gintaras Zaleskis, Sima Garberytė, et al. · Journal of Cancer · 6
PDF
Serum VEGF Potential as a Biomarker for Diagnosis of Female Unexplained Infertility: Does Atopy Matter?
2025 · Gabija Didžiokaitė, Austėja Grudytė, et al. · International Journal of Molecular Sciences · 2
PDF
Deciphering immune tumor subtypes through microenvironment profiling
2025 · Agata Mlynska, Egle Zymantaite, et al. · South East European Journal of Immunology · 1
Modulatory Effects of Antioxidant Supplementation on Serum Oxidative Stress Biomarkers MDA and T-AOC in Females with Unexplained Infertility
2026 · Gabija Didžiokaitė, Aida Kuznecovaitė, et al. · Antioxidants
Three-dimensional H&E histopathology powered by deep learning-assisted multimodal nonlinear microscopy
2025 · Virginijus Barzda, Martynas Riauka, et al. · Research Square
Soluble PD-1/PD-L1 in prostate cancer: immune cell associations and clinical implications
2025 · Margarita Žvirblė, Žilvinas Survila, et al. · South East European Journal of Immunology
Molekulinių prostatos vėžio biožymenų tyrimai ligos prognozavimui ir gydymo predikcijai
2025 · Margarita Žvirblė
Association between soluble factors sPD-1 and sPD-L1 and cellular immunological characteristics depending on the course of the disease, before and after radical prostatectomy
2023 · M. Zvirble, Z. Survila, et al. · European Urology Open Science
Atezolizumab Retains Cellular Binding to Programmed Death Ligand 1 Following AerosolizationviaMesh Nebulizer
2023 · GINTARAS ZALESKIS, MARTYNAS TALAIKIS, et al. · Anticancer Research
PDF
Soluble sPD-1 and sPD-L1 factors and cellular immunological characteristics in blood of prostate cancer patients, following radical prostatectomy
2022 · M. Zvirble, L. Šimkus, et al. · European Urology Open Science
Works count: 12
Citation count: 27
H-index: 3
I10-index: 1
Year
Topic
Type